DNA methylation-based classification of central nervous system tumours

D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf… - Nature, 2018 - nature.com
Accurate pathological diagnosis is crucial for optimal management of patients with cancer.
For the approximately 100 known tumour types of the central nervous system, standardization …

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

F Sahm, D Schrimpf, D Stichel, DTW Jones… - The lancet …, 2017 - thelancet.com
Background The WHO classification of brain tumours describes 15 subtypes of meningioma.
Nine of these subtypes are allotted to WHO grade I, and three each to grade II and grade III. …

Sarcoma classification by DNA methylation profiling

C Koelsche, D Schrimpf, D Stichel, M Sill… - Nature …, 2021 - nature.com
Sarcomas are malignant soft tissue and bone tumours affecting adults, adolescents and
children. They represent a morphologically heterogeneous class of tumours and some entities …

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for …

DE Reuss, F Sahm, D Schrimpf, B Wiestler… - Acta …, 2015 - Springer
Diffuse gliomas are represented in the 2007 WHO classification as astrocytomas,
oligoastrocytomas and oligodendrogliomas of grades II and III and glioblastomas WHO grade IV. …

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

…, M Ratliff, R Harbottle, A Benner, D Schrimpf… - Nature medicine, 2018 - nature.com
The oncometabolite (R)-2-hydroxyglutarate (R-2-HG) produced by isocitrate dehydrogenase
(IDH) mutations promotes gliomagenesis via DNA and histone methylation. Here, we …

Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience

…, D Stichel, F Sahm, DTW Jones, D Schrimpf… - Acta …, 2018 - Springer
Recently, we described a machine learning approach for classification of central nervous
system tumors based on the analysis of genome-wide DNA methylation patterns [ 6 ]. Here, we …

Novel, improved grading system (s) for IDH-mutant astrocytic gliomas

M Shirahata, T Ono, D Stichel, D Schrimpf… - Acta …, 2018 - Springer
According to the 2016 World Health Organization Classification of Tumors of the Central
Nervous System (2016 CNS WHO), IDH-mutant astrocytic gliomas comprised WHO grade II …

Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology

…, AK Suwala, GH Gielen, M Sill, D Schrimpf… - Nature medicine, 2023 - nature.com
The large diversity of central nervous system (CNS) tumor types in children and adolescents
results in disparate patient outcomes and renders accurate diagnosis challenging. In this …

TERT promoter mutations and risk of recurrence in meningioma

F Sahm, D Schrimpf, A Olar, C Koelsche… - Journal of the …, 2016 - academic.oup.com
The World Health Organization (WHO) classification and grading system attempts to predict
the clinical course of meningiomas based on morphological parameters. However, because …

Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers

…, D Sturm, D Capper, J Meyer, D Schrimpf… - Acta …, 2015 - Springer
Pediatric glioblastoma (pedGBM) is amongst the most common malignant brain tumors of
childhood and carries a dismal prognosis. In contrast to adult GBM, few molecular prognostic …